Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. www.igcinc.us

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

MARCH 25, 2019

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). 2030 , 2068, 2070; Pub. 5) All books, records, and research, including formulas, microfilm, tapes, and data which are used, or intended for use, in violation of this subchapter. . (6)

Banking 45

Banking Law Marijuana State Laws 45

Cannabis Law Report

DECEMBER 30, 2019

Worldwide legal marijuana sales have more than tripled between 2014 and 2018 to almost $11 billion, and most analysts on Wall Street predict that legal weed could generate anywhere from $50 billion to $200 billion a year by the time 2030 rolls around. entirely illegal, prone to abuse, and not recognized as having any medical benefits).

Banking 64

Banking Business Cannabis THC 64